Notice of Privacy Incident
Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.

Drugs and Therapeutics (D & T) Committee Meeting Results for: March 24, 2010

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Bepreve	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Vivitrol	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Colcrys	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Sabril	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Twynsta	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Apriso	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Besivance	New Drug Appeal	Require Prior Approval	Prior Approval Required
Ranexa	New Drug Appeal	Require Prior Approval	Prior Approval Required
Vimpat	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Required
Lamictal XR	New Drug Appeal	Removed from Agenda Prior to Mtg	Prior Approval Required
Ulesfia	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Required
Zenpep	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Xibrom	PDL Appeal	Require Prior Approval	Prior Approval Required
Istalol	PDL Appeal	Require Prior Approval	Prior Approval Required

Footer